Ling-chao Chen

No. 12 Wulumuqi Middle Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.

Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.

Journal: Molecular medicine reports

Published: October 20, 2015

TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.

TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.

Journal: International journal of clinical and experimental pathology

Published: July 29, 2015

Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.

Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.

Journal: Journal of neuro-oncology

Published: July 11, 2015

miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.

miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.

Journal: Oncology reports

Published: June 03, 2015

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.

Journal: Oncotarget

Published: March 29, 2015

TRIM28 as an independent prognostic marker plays critical roles in glioma progression.

TRIM28 as an independent prognostic marker plays critical roles in glioma progression.

Journal: Journal of neuro-oncology

Published: March 16, 2015

MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.

MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.

Journal: Molecular cancer

Published: December 29, 2013

Astroblastoma: rare incidence and challenges in the pattern of care.

Astroblastoma: rare incidence and challenges in the pattern of care.

Journal: World neurosurgery

Published: November 24, 2013

Serological identification of URGCP as a potential biomarker for glioma.

Serological identification of URGCP as a potential biomarker for glioma.

Journal: CNS neuroscience & therapeutics

Published: October 26, 2013

Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.

Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.

Journal: Cancer letters

Published: July 17, 2013

Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.

Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.

Journal: CNS neuroscience & therapeutics

Published: January 18, 2013

MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma.

MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma.

Journal: CNS neuroscience & therapeutics

Published: December 10, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026